Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Mankind Pharma Ltd spurts 1.46%, up for third straight session
Mankind Pharma Ltd is quoting at Rs 2353.3, up 1.46% on the day as on 12:49 IST on the NSE. The stock is down 3.25% in last one year as compared to a 1.62% fall in NIFTY and a 12.19% fall in the Nifty Pharma index.
Top Gainers & Losers on Feb 26: Tejas Networks, KSB, Mankind Pharma, Tata Motors, Finolex Cables among top gainers
The Indian stock market remained largely unchanged on February 26, with the Nifty 50 up 0.06% at 25,496 and the S&P BSE Sensex flat at 82,248. Broader markets showed mixed results, while US stocks rallied on Nvidia's strong earnings, boosting Asian markets as well.
Mankind Pharma among 4 stocks showing bullish RSI upswing
Four Nifty200 stocks, including Mankind Pharma and Aurobindo Pharma, signalled strengthening momentum on February 25 as their RSI crossed above the 50 mark. The RSI Trending Up scan highlights improving price strength, often interpreted by traders as a potential buying opportunity amid sustained upward movement.
Lloyds Metals & Energy among 6 stocks flash bullish signals, indicating possible uptrend
Six Nifty500 stocks, including Lloyds Metals & Energy, Mankind Pharma and National Aluminium Company, formed a bullish White Marubozu pattern on February 25, signalling strong buying interest. The candlestick formation indicates sustained upward momentum, with traders viewing it as a potential early indicator of further price strength in the near term.
Buy Mankind Pharma; target of Rs 2640: Motilal Oswal
Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2640 in its research report dated April 29, 2026.
Trade Spotlight: How should you trade Ather Energy, Alembic Pharma, GMR Airports, Gujarat Fluorochemicals, Mankind Pharma, and others on July 1?
The market is likely to remain range-bound as long as it trades below the previous week's high. Below are some short-term trading ideas to consider.